Publikationen in Zusammenarbeit mit Forschern von Universidad Politécnica de Valencia (8)

2024

  1. New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2022

  1. Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1

    International journal of molecular sciences, Vol. 23, Núm. 15

2020

  1. Relevance of Nrf2 and heme oxygenase-1 in articular diseases

    Free Radical Biology and Medicine, Vol. 157, pp. 83-93

2019

  1. Emerging therapeutic agents in osteoarthritis

    Biochemical Pharmacology, Vol. 165, pp. 4-16

  2. Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

2018

  1. Myeloid heme oxygenase-1 regulates the acute inflammatory response to zymosan in the mouse air pouch

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  2. Nrf2 as a therapeutic target for rheumatic diseases

    Biochemical Pharmacology, Vol. 152, pp. 338-346

2017

  1. Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles

    Journal of Controlled Release, Vol. 248, pp. 60-70